RARG and Osteochondroma: Hematoxylin-eosin staining of osteochondroma explants did not show significant changes in overall view seven days after NRX204647 RARγ agonist treatment but did however show an evident decrease in the staining intensity in RARγ-agonist treated groups (Figure 1C–F).